Oncolytic Virus Adaptations for Extreme Environments

The present inventive concept discloses novel methods and systems for adapting oncolytic viruses to treat cancer in high-altitude, high-security, disaster-stricken, extreme weather, and high-radiation environments.

The original patent disclosed oncolytic virus growth methods and antitumor agents. However, these methods and agents may not be effective in extreme environments. The present inventive concept addresses this limitation by providing specialized oncolytic virus adaptations for these unique operational environments.

The inventive concept comprises novel methods and systems for adapting oncolytic viruses to treat cancer in various extreme environments. For instance, claim 1 discloses a method for treating cancer in a high-altitude environment by administering an antitumor agent comprising a coxsackievirus and an antimetabolite to a patient in need thereof at an altitude above 2500 meters. Claim 2 discloses a system for delivering oncolytic viruses to a patient in a remote or disaster-stricken area, comprising a portable virus storage unit and a remote-controlled administration device. Claim 3 discloses a method for enhancing the infectivity of oncolytic viruses in extreme weather conditions by pre-treating the oncolytic viruses with a cryoprotectant prior to administration.

The new claims provide a novel and non-obvious adaptation of oncolytic viruses to extreme environments, which is not disclosed in the original patent. The inventive step lies in recognizing the need for specialized oncolytic virus adaptations for these unique operational environments and providing solutions that address these specific challenges.

Alternative embodiments of the inventive concept may include adapting oncolytic viruses for use in other extreme environments, such as high-temperature or high-humidity environments. Variations may include using different types of oncolytic viruses or antitumor agents, or incorporating additional components to enhance the effectiveness of the treatment.

The inventive concept has significant commercial potential in the oncology market, particularly in regions prone to extreme weather conditions or with high-security needs. The target industries may include pharmaceutical companies, biotechnology companies, and healthcare providers specializing in cancer treatment.